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Abstract: 
Malaria imposes great socio-economic burden on humanity, and afflicts approximately 90 countries and territories in the 
tropical and subtropical regions, almost one half of them are in Africa, South of Sahara. Sequestration of parasitized 
erythrocytes within the small vessels of vital organs is a key event in the pathogenesis of malaria and responsible of 
virulence of Plasmodium falciparum parasite. To find out whether the ability of infected red blood cells (IRBCs) to adhere to 
a specific receptor is a risk factor for developing severe clinical manifestation of the disease, in-vitro cytoadhesion and 
inhibition experiments were performed on field isolates obtained from five symptomatic and five asymptomatic patients 
inhabiting   Gazira State, Central Sudan. The results showed significant lower levels (p<0.02) of cytoadhesion among 
asymptomatic compared to symptomatic patients.  Percent inhibition by FA6-152, a monoclonal antibody for CD36, was 
comparable between the two study groups. However, the inhibition by CSA protein was less among symptomatic compared 
to asymptomatic patients. These results shed light on possible role of CSA receptors expressed on endothelial cells in 
ameliorating the events associated with the severe phenotype of the disease. 
 
INTRODUCTION 
 Plasmodium falciparum malaria remains the major 
cause of death in Sub Saharan Africa, mostly among 
children below the age of five years. According to 
the mechanical hypothesis which was first proposed 
in 1894 by Marchiafava and Bignami [cited by 1], 
the pathogenicity of P. falciparum results from its 
unique ability to adhere to capillary and post-
capillary venular endothelium during the second 
half of the 48-h erythrocytic life cycle, a process that 
is called cytoadherence. The resulting sequestration 
of infected red blood cells (IRBCs) leads to 
alterations in microcirculatory blood flow, 
metabolic dysfunction, and, as a consequence, many 
of the manifestations of severe falciparum malaria 
[2]. It has been reported that patients who die in the 
acute phase of falciparum malaria have intense 
sequestration of erythrocytes containing mature 
forms of the parasite in the microvasculature of vital 
organs [reviewed by 3]. 
 
In vitro models have shown that erythrocytes 
parasitized with mature stage of P.falciparum may 
adhere to receptors found on the endothelial cell 
surface. A key question is whether the ability of 
IRBCs to adhere to a specific receptor is a risk factor 
for developing severe clinical manifestation of the 
disease. Several studies among different 
populations were carried out to investigate the 
correlation between binding to specific host receptor 
and disease outcome. However, results obtained 
from these studies were considerably variable. A 
study among Malawian children [4] has 
investigated the binding of purified receptors CD36 
(cluster of differentiation 36), ICAM-1 (intercellular 
adhesion molecule), CSA (chondroitin sulphate A) 
and thrombmodulin (TM) to fresh parasite isolates 
cultured to trophozoite stage from children with 
uncomplicated and severe malaria. Eighty five 
percent of all isolates bound to CD36, and 56% 
bound to ICAM-1. Fewer bound to CSA (27%) or 
TM (15%). However, after standardizing for 
parasitemia, parasite isolates from children with 
uncomplicated disease bound at higher levels to all 
receptors, significantly so for ICAM-1 and CD36. 
Conversely, a similar study at Kilifi on the Kenyan 
coast using cryopreserved and thawed isolates, has 
reported that the binding to ICAM-1 was highest 
among isolates from cerebral non-anaemic malaria 
patients whereas CD36 binding was slightly 
elevated among non-severe cases [5]. The study also 
reported that very few isolates could bind to 
VCAM-1 and none to E-selectin. Another study 
among Gambian children with falciparum malaria 
using monoclonal antibodies also showed that CD36 
and ICAM-1 antigens were the major mediators of 
adhesion of IRBCs to vascular endothelium [6]. 
Cytoadherence characteristics were also studied 
among Thai patients [7] with complicated and non-
complicated malaria using in vitro model of human 
lung endothelial cells (HLEC). According to this 





with malaria severity and in consistence to previous 
studies CD36 was the main receptor in patients with 
uncomplicated malaria while ICAM-1 and CSA 
were major receptors among those with complicated 
malaria. Moreover, VCAM-1 and E-selectin played 
minor role in cytoadhesion among both groups. In a 
study conducted in non-immune travellers [8], it 
has been shown that IRBCs from severe malaria 
isolates appeared to adhere more frequently and/or 
strongly to ICAM-1 and CD36 in comparison with 
uncomplicated cases.  
 
Recent attempts to explain the variable pathology 
seen in malaria stated that apposition of IRBCs 
activate signalling pathways. This is dependent, at 
least in part, on the cytoadherence characteristics of 
the invading isolate, such that the avidity of the 
IRBC for the receptor on host endothelium is 
proportional to the level of activation of the 
signalling pathways [9]. It has also been proposed 
that the balance between positive and negative 
regulation of genes involved in inflammation and 
cell death, by IRBCs and TNF will contribute to 
endothelial pathology during malarial infection [9]. 
 The current study is a preliminary study intended 
to define host endothelial cell receptors favoured by 
the field isolates from Gazira state, Central Sudan 
and the impact of adherence to these receptors on 
the pathogenicity of malaria. 
 
SUBJECTS AND METHODS 
Subjects included in this study were inhabitants of 
Wadmadani city, Gazira State, central Sudan or its 
suburbs, an area characterized by seasonal malaria 
transmission. The experiment included five field 
isolates of P.falciparum from symptomatic children 
attending Wadmadani paediatric hospital and five 
isolates from asymptomatic children during 
screening for P.falciparum in a primary school in the 
area. Diagnosis of malaria was confirmed by 
immuonochromatographic rapid test (Hexagon 
Malaria CombiTM; Human, Wiesbaden, Germany) 
and Giemsa stained blood films. Classification of 
cases was based on clinical signs, and laboratory 
findings of malaria at the time of presentation.  
One and half mililiters of venous blood were drown 
in citrate Vacutainer® tube (BD, Franklin Lakes, NJ) 
from each child enrolled after obtaining a signed 
consent form by parents or guardians. The study 
protocol was approved by the Ethical Committee of 
the institute of endemic diseases, University of 
Khartoum. 
 
Human lung endothelial cells (HLEC) culture 
HLECs are used in this experiment (gift from 
Laboratoire de Parasitologie Expe´rimentale, 
Faculte´ de Me´decine, Universite´ de la 
Me´diterrane´e, Marseille, France). The cells are 
characterized by expressing CSA, CD36 and ICAM-
1 receptors. Cells were cultured in DME/F-12 media 
(Sigma, USA) at a density of 3,000 Cells/well in 12-
well IFA slides for 24 to 48 hours under standard 
conditions to reach confluence as described by [10]. 
Maturation and enrichments of parasite isolates 
Field isolates were cultured as previously described 
[11] in RPMI 1640 medium supplemented with 0.2% 
sodium bicarbonate, 0.25% AlbuMax, 0.6% hepes 
and 10 µg/ml gentamicin and incubated in a candle 
jar at 37°C. Cultures were harvested after 48 – 60 
hours when parasites were mostly at the mature 
stage of schizonts and trophozoites. Erythrocytes 
Infected with mature stages were enriched by 
gelatin sedimentation technique described by [12] 
and the suspension of each isolate was used in 
duplicate static cytoadhesion and inhibition assays 
with HLECs. Parasitemia after gelatin 
sedimentation was adjusted to 1.5x1010 IRBCs/ml.       
 
Static cytoadhesion assays 
Static cytoadhesion assays were carried out in 
duplicate for each sample on 12-well IFA slides on 
which HLECs had been cultured to confluence [10] 
Briefly, the cell culture media was aspirated 
carefully from the edge of each well and 20 µl of 
(IRBCs) suspension prepared by gelatin 
sedimentation and 20 µl of RPMI 1640 media 
supplemented with 10 µg/ml gentamicin were 
added to each well. The IRBCs were allowed to 
cytoadhere to the confluent HLECs for 2 h at 37°C. 
Unattached IRBCs were removed by washing with 
RPMI 1640 media, and the cells were fixed for 1 
hour with 2.5% glutaraldehyde (Sigma, USA). 
Number of IRBCs adhering to HLECs was counted 
under inverted microscope in four fields for each 
well (Fig 1). The result expressed as IRBCs/mm2 
was calculated as follows: 
                    IRBCs/mm2 = number of IRBCs in each 
field/area of field. 
 
Average IRBCs/mm2 = Sum IRBCs/mm2 of the four 
fields/4. 
 
Cytoadhesion inhibition assays 
 Soluble CSA at a concentration of 100 µg/ml 
(Fluka; 27042) and FA6-152 anti-CD36 monoclonal 
antibody at a concentration of 5 mg/ml were used 
to inhibit cytoadhesion to CSA and CD36 receptors 
respectively. Briefly, 20 µl IRBCs suspension from 
each isolate were incubated with HLECs in the 
presence of either 20 µl of soluble CSA or anti-CD36 
mAb. IRBCs/mm2 after inhibition were calculated 
by the same procedure used for cytoadhesion assays 
(Fig 2,3). The percent inhibition of cytoadhesion was 
calculated using the following equation: 
% inhibition = 1-(average IRBCs/mm2 after 
inhibition) / average IRBCs/mm2 without 
inhibition) * 100. 
Mann-Whitney tests were used to evaluate the 
statistical significance of differences.  
 
RESULTS 
Average cytoadherence counted as IRBCs/mm2 
was significantly higher among symptomatic 
  
patients compared to asymptomatics (p
1). Inhibition of cytoadhesion using soluble CSA 
protein reduced the cytoadhesion by 5.04% and 
40.8% (p<0.08) among symptomatic and 
TABLE 1: LEVELS OF CYTOADHESION AND INHIBITION OF CYTOADHESION BY CSA PROTEIN AND EA6
ANTI CD36 MAB AMONG THE STUDY GROUPS
 
Parameter (average±SD) Symptomatic          infection
Cytoadhesion (IRBC/mm2) 480.20±127.0
% inhibition by CSA 
protein 
%inhibition by FA6-152 
*Statistically significant difference; p<0.05
 
FIGURE 1: CYTOADHESION OF AN ISOLATE FROM ASYMPTOMATIC PATIENT (A) 
 
 
FIGURE 2: INHIBITION OF CYTOADHESION BY SOLUBLE 
ASYMPTOMATIC PATIENT (A) AND SYMPTOMATIC PATIENT (B)
 
       
 
FIGURE 3: INHIBITION OF CYTOADHESION BY FA6
ASYMPTOMATIC PATIENT (A) AND SYMPTOMATIC 
 












<0.02), (table asymptomatic patients respectively. On the other 
hand, % inhibition by FA6-152 anti-
comparable between the two study groups (Fig 4).
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In human P. falciparum malaria infection, IRBCs 
either sequester or are removed from the circulation 
primarily by the spleen. The balance between 
splenic clearance and sequestration, which allows 
the parasite to evade the immune system, is a major 
determinant of the rate of increase and magnitude 
of the infecting parasite burden. Within this 
paradigm, pathogenicity is proportional to the size 
of the sequestered parasite burden and the pattern 
of vital organ sequestration [reviewed by 3]. A key 
question is whether the ability of IRBCs to adhere to 
a specific receptor is a risk factor for developing 
severe clinical manifestation of the disease. In an 
attempt to answer this question and to determine 
the relative importance of CD36 and CSA receptor 
molecules for wild-type parasites among Sudanese, 
we have used static binding assays of IRBCs taken 
directly from the peripheral blood of patients with 
falciparum malaria to HLECs. 
 
Our results confirmed the correlation between 
cytoadhesion and disease severity. Indeed, the level 
of cytoadhesion increased by 3.5 folds among 
symptomatic compared to asymptomatic patients. 
Inhibitions assays were carried out to evaluate the 
contribution of each of the selected receptors to the 
level of cytoadherence. Our results showed that 
(91.7%) of all tested isolates bound to CD36 
receptor. This is consistent with previous studies 
using wild-type isolates among Thai [7], Malawian 
[4] and Kenyan [5] patients with severe and 
uncomplicated malaria. All isolates from Thai and 
Kenyan patients and 85% of Malawian patients 
bound to purified CD36 receptor. Similar results 
were also obtained with lab adapted strains [12]. 
However, the absence of significant difference in the 
percent cytoadhesion inhibition between the two 
study groups (p<0.7) indicates lack of correlation 
between CD36 binding and clinical severity of the 
disease. This is in agreement with previous studies 
reported among Kenyan children [5]. In contrast to 
our results, CD36 was found to be associated with 
uncomplicated malaria among Thai patients [7] and  
 
Malawian children [4]. It was suggested that this 
negative association between CD36 binding and 
disease severity might be due to the sequestration of 
parasites in less harmful parts of the body.  
Interestingly, a study among non-immune travelers 
reported that IRBCs from severe malaria appeared 
to adhere more frequently and/or strongly to 
ICAM-1 and CD36 in comparison with 
uncomplicated cases [8]. The contradicting reports 
on the association between CD36 binding and 
severity of malaria among the different populations 
might be attributed, at least partially, to 
polymorphism in the gene encoding CD36 protein. 
It has been reported that African populations 
contain an exceptionally high frequency of 
mutations in CD36 [13]. To our knowledge no 
studies were conducted so far on CD36 
polymorphism among Sudanese population and its 
relation to malaria severity. 
 
On the other hand, the binding of IRBCs to CSA 
receptors was quite variable among the different 
isolates. Although CSA receptor is closely 
associated with placental malaria where it is 
expressed on syncytiotrophoblasts that line the 
placental intervillous space, some reports pointed to 
the occurrence of CSA binding variants in non-
pregnant individuals [14].The restriction of the CSA 
specific phenotype to the placenta is ruled out by 
the desequestration of IRBCs obtained when P. 
falciparum infected non-pregnant Saimari sciureus 
monkeys are injected with CSA. The specificity of 
this desequestration demonstrates that IRBCs are 
able to cytoadhere to CSA in the microvasculature 
of non-pregnant animals of this primate species, as 
well as in the placenta [10]. 
 
According to our data, only 58.3% of all study 
isolates adhere to CSA compared to 91.7% 
adherence to CD36 receptors. The reduced 
adherence to CSA receptors compared to CD36 is in 
agreement with previous studies among Malawian 


































showed that the average percent cytoadhesion 
inhibition by CSA protein was higher among the 
asymptomatic group. However, the difference was 
not statistically significant probably due to the small 
sample size. In agreement with our results, a non-
significant increase in CSA binding among 
Malawian children with uncomplicated malaria was 
reported [4].  In contrast, a higher percent of 
cytoadhesion inhibition by CSA antibodies among 
complicated malaria cases compared to 
uncomplicated ones was reported among Thai 
patients [7]. 
 
On conclusion, this study shed light on the 
importance of CSA as a putative receptor for 
uncomplicated or asymptomatic malaria among 
Sudanese in the study area and may protect against 
developing severe symptoms. It is possible that 
binding to CSA receptors in the study population 
does not provoke harmful immune response. 
Moreover, the high percentage of cytoadhesion 
inhibition by CD36 mAb may reflect a strong 
selective pressure exerted by CD36 on the parasite 
isolates in this region. It is possible that P.falciparum 
parasites may use this receptor in vivo to promote 
parasite survival and immune evasion.  
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